Liminatus Pharma LIMN
NASDAQ LIMN
$3.10 -0.02 (-0.64%)
As of: Oct 22, 2026 · 12:32 PM EDT

Liminatus Pharma (LIMN) Change in Other Operating Liabilities (2024 - 2026)

Updated

Analysis

Liminatus Pharma (LIMN) Change in Other Operating Liabilities (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,169.59 Bn 1,138.18 Bn 19.71 Bn -
2 Johnson & Johnson 643.18 Bn 561.71 Bn 17.26 Bn -972.00 Mn
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn -
4 Merck 361.55 Bn 315.92 Bn 12.21 Bn -
5 Novartis Ag 302.33 Bn 266.32 Bn 11.24 Bn -
6 Astrazeneca 267.31 Bn 241.00 Bn 12.86 Bn -
7 Amgen 241.52 Bn 196.92 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 193.17 Bn 167.37 Bn 6.22 Bn -
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn -112.00 Mn
10 Liminatus Pharma 3.00 Mn -2.99 Mn - 6,844.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,844.00
Mar 31, 2026 -14,999.00
Dec 31, 2025 31,533.00
Sep 30, 2025 7,500.00
Jun 30, 2025 -83,500.00
Mar 31, 2025 -18,000.00
Sep 30, 2024 -2,000.00
API Access

Liminatus Pharma Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=LIMN&period=max&api_key=YOUR_API_KEY